Amphastar Pharmaceuticals (AMPH) Current Taxes (2013 - 2026)

Amphastar Pharmaceuticals' Current Taxes history runs 14 years deep, the most recent figure standing at $414000.0 for Q1 2026.

• In Q1 2026, Current Taxes fell 97.27% year-over-year to $414000.0; the TTM figure through Mar 2026 stood at $414000.0 (down 97.27% YoY), while the FY2025 annual figure was $239000.0, down 97.53% from the prior year.
• Current Taxes was $414000.0 for Q1 2026 at Amphastar Pharmaceuticals, up from $239000.0 in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $31.1 million in Q3 2023 to a low of $239000.0 in Q4 2025.
• Historically, Current Taxes has averaged $7.2 million across 5 years, with a median of $4.6 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Current Taxes soared 2864.15% in 2023, then slumped 97.53% in 2025.
• A 5-year view of Current Taxes shows it stood at $4.6 million in 2022, then tumbled by 64.8% to $1.6 million in 2023, then soared by 500.62% to $9.7 million in 2024, then plunged by 97.53% to $239000.0 in 2025, then surged by 73.22% to $414000.0 in 2026.
• The last three Current Taxes figures came in at $414000.0 (Q1 2026), $239000.0 (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.